Endotracheal Tubes Coated with Antiseptics Decrease Bacterial Colonization of the Ventilator Circuits, Lungs, and Endotracheal Tube

Background: Formation of a bacterial biofilm within the endotracheal tube (ETT) after tracheal intubation is rapid and represents a ready source of lung bacterial colonization. The authors investigated bacterial colonization of the ventilator circuit, the ETT, and the lungs when the ETT was coated with silver-sulfadiazine and chlorhexidine in polyurethane, using no bacterial/viral filter attached to the ETT. Methods: Sixteen sheep were randomized into two groups. Eight sheep were intubated with a standard ETT (control group), and eight were intubated with a coated ETT (study group). Animals were mechanically ventilated for 24 h. At autopsy, the authors sampled the trachea, bronchi, lobar parenchyma, and ETT for quantitative bacterial cultures. Qualitative bacterial cultures were obtained from the filter, humidifier, inspiratory and expiratory lines, and water trap. ETTs were analyzed with light microscopy, scanning electron microscopy, and laser scanning confocal microscopy. Results: In the control group, all eight ETTs were heavily colonized (105–108 colony-forming units [cfu]/g), forming a thick biofilm. The ventilator circuit was always colonized. Pathogenic bacteria colonized the trachea and the lungs in five of eight sheep (up to 109 cfu/g). In the study group, seven of eight ETTs and their ventilator circuits showed no growth, with absence of a biofilm; one ETT and the respective ventilator circuit showed low bacterial growth (103–104 cfu/g). The trachea was colonized in three sheep, although lungs and bronchi showed no bacterial growth, except for one bronchus in one sheep. Conclusions: Coated ETTs induced a nonsignificant reduction of the tracheal colonization, eliminated (seven of eight) or reduced (one of eight) bacterial colonization of the ETT and ventilator circuits, and prevented lung bacterial colonization.

[1]  J. A. Bass,et al.  A rat model of chronic respiratory infection with Pseudomonas aeruginosa. , 2015, The American review of respiratory disease.

[2]  P. Pronovost,et al.  Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999–2000 , 2003, Critical care medicine.

[3]  M. Stylianou,et al.  Bacterial colonization of the respiratory tract following tracheal intubation—Effect of gravity: An experimental study* , 2003, Critical care medicine.

[4]  P. Freestone,et al.  Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes , 2003, The Lancet.

[5]  David S. Jones,et al.  Characterisation and evaluation of novel surfactant bacterial anti‐adherent coatings for endotracheal tubes designed for the prevention of ventilator‐associated pneumonia , 2003, The Journal of pharmacy and pharmacology.

[6]  A. Prince Biofilms, antimicrobial resistance, and airway infection. , 2002, The New England journal of medicine.

[7]  G. O’Toole Microbiology: A resistance switch , 2002, Nature.

[8]  Frederick M. Ausubel,et al.  Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation , 2002, Nature.

[9]  H. Hansma,et al.  Elongation Correlates with Nutrient Deprivation in Pseudomonas aeruginosa Unsaturated Biofilms , 2002, Microbial Ecology.

[10]  M. Kollef,et al.  Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. , 2002, Chest.

[11]  H. Dupont,et al.  Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: Results of the Eole study , 2002, Critical care medicine.

[12]  L. Sampath,et al.  Safety and Efficacy of an Improved Antiseptic Catheter Impregnated Intraluminally With Chlorhexidine , 2001, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[13]  Roger E. Bumgarner,et al.  Gene expression in Pseudomonas aeruginosa biofilms , 2001, Nature.

[14]  L. Sampath,et al.  In Vitro and In Vivo Efficacy of Catheters Impregnated With Antiseptics or Antibiotics: Evaluation of the Risk of Bacterial Resistance to the Antimicrobials in the Catheters , 2001, Infection Control & Hospital Epidemiology.

[15]  J. Costerton,et al.  Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.

[16]  Carlene A. Muto,et al.  A randomized crossover study of silver-coated urinary catheters in hospitalized patients. , 2000, Archives of internal medicine.

[17]  L. Brochard,et al.  Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. , 2000, JAMA.

[18]  S. Wilson,et al.  New Epidemiology for Postoperative Nosocomial Infections , 2000, The American surgeon.

[19]  A. Wilkes,et al.  The bacterial and viral filtration performance of breathing system filters* , 2000, Anaesthesia.

[20]  David S. Jones,et al.  Implications of endotracheal tube biofilm for ventilator-associated pneumonia , 1999, Intensive Care Medicine.

[21]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[22]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[23]  C. Potera Forging a Link Between Biofilms and Disease , 1999, Science.

[24]  O. Wenker,et al.  A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. , 1999, The New England journal of medicine.

[25]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[26]  C. Alex,et al.  Extending ventilator circuit change interval beyond 2 days reduces the likelihood of ventilator-associated pneumonia. , 1998, Chest.

[27]  M. Muller,et al.  Silvazine (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. , 1997, Burns : journal of the International Society for Burn Injuries.

[28]  A J DeRiso,et al.  Chlorhexidine Gluconate 0.12% Oral Rinse Reduces the Incidence of Total Nosocomial Respiratory Infection and Nonprophylactic Systemic Antibiotic Use in Patients Undergoing Heart Surgery , 1996, Chest.

[29]  Andrew N. Rowan Guide for the Care and Use of Laboratory Animals , 1996 .

[30]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[31]  D. Craven,et al.  Epidemiology of nosocomial pneumonia. New perspectives on an old disease. , 1995, Chest.

[32]  P. Suci,et al.  Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms , 1994, Antimicrobial Agents and Chemotherapy.

[33]  M. R. Brown,et al.  Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. , 1992, The Journal of antimicrobial chemotherapy.

[34]  R. Rodríguez-Roisín,et al.  Pulmonary Aspiration of Gastric Contents in Patients Receiving Mechanical Ventilation: The Effect of Body Position , 1992, Annals of Internal Medicine.

[35]  M. Hemmer Nosocomial pulmonary infections , 1990 .

[36]  T. Inglis,et al.  Tracheal tube biofilm as a source of bacterial colonization of the lung , 1989, Journal of clinical microbiology.

[37]  A. Tomasz,et al.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. , 1986, Journal of general microbiology.

[38]  D. Prough,et al.  Nosocomial pulmonary infection: Possible etiologic significance of bacterial adhesion to endotracheal tubes , 1985, Critical care medicine.

[39]  B. Make,et al.  Contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia? , 1984, The American review of respiratory disease.

[40]  T. Bush,et al.  The potential role of respiratory therapy equipment in cross infection. A study using a canine model for pneumonia. , 1983, The American review of respiratory disease.

[41]  W. R. Mccabe,et al.  Contamination of mechanical ventilators with tubing changes every 24 or 48 hours. , 1982, The New England journal of medicine.

[42]  L. Quesnel,et al.  Synergism between chlorhexidine and sulphadiazine. , 1978, The Journal of applied bacteriology.

[43]  M. Mandelli,et al.  Early onset pneumonia: a multicenter study in intensive care units , 2004, Intensive Care Medicine.

[44]  ohn,et al.  A COMPARISON OF TWO ANTIMICROBIAL-IMPREGNATED CENTRAL VENOUS CATHETERS , 2000 .

[45]  A D Russell,et al.  Antimicrobial activity and action of silver. , 1994, Progress in medicinal chemistry.

[46]  E. Germann,et al.  Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns. , 1991, The Journal of burn care & rehabilitation.

[47]  K. Tack,et al.  Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin. , 1985, Chemotherapy.